Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Events
  • Markets
  • News
  • Psychedelics

Women’s Footprint In Psychedelics Is Undeniable, Benzinga’s Psychedelics Advisory Council’s Six New Trailblazers

By Lara Goldstein
Today, 7:29 PM
In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council.

KONEF

Read More
6 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psyched: Musk’s Empathy Tweets, Psychedelics In Congress, Oregon’s Opt-Outs, MAPS’ MDMA Trial And More

By Lara Goldstein
Today, 7:29 PM
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

AGNPF

Read More
3 minute read
  • Cannabis
  • Contracts
  • Financing
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics

Ketamine Therapy: Revitalist’s New Financing Option, Irwin Naturals Expands Chain Of Clinics

By Lara Goldstein
Today, 7:29 PM
Revitalist Increases Patient Access By Financing Costs With M-Lend Financial

IWINF

Read More
2 minute read
  • Cannabis
  • Events
  • Markets
  • News
  • Psychedelics

What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out

By Lara Goldstein
Today, 7:29 PM
Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e.

FTHWF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics

Justice Dept Grants $1M To Non-Profits To Help Stem Teen Mental Health Issues & School Violence

By Lara Goldstein
Today, 7:29 PM
A silent epidemic is moving across the country. Each year, from one in five children in the U.S., show signs or symptoms of a mental health disorder, be it depression, anxiety or substance abuse.

RVLWF

Read More
2 minute read
  • Cannabis
  • Contracts
  • Global
  • Management
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics

Psychedelics Companies Are Teaming Up To Offer Access Veterans

By Lara Goldstein
Today, 7:29 PM
Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on  access needs for veterans. 

AWKNF

Read More
2 minute read
  • Cannabis
  • Global
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder

By Lara Goldstein
Today, 7:29 PM
Awakn Life Sciences Corp. (OTCQB: AWKNF), the biotech company focused on addiction treatments, has signed a licensing partnership agreement with US ketamine therapy clinics owner Revitalist Lifestyle and Wellness Ltd.

AWKNF

Read More
6 minute read
  • Cannabis
  • Exclusives
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

10 Psychedelics CEOs To Pay Attention To In 2022

By Javier Hasse
Today, 7:29 PM
By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public.

ATAI

Read More
1 minute read
  • Cannabis
  • Management
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics

Ketamine-Clinics Revitalist Raises Nearly $4M In Second Round Of Private Placement

By Lara Goldstein
Today, 7:29 PM
There are two ways in which companies can raise funds: public offerings or direct sale of shares to investors, usually via private placements. 

RVLWF

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service